Article Versions Notes

Li X, Duan W, Du L, Chu D, Wang P, Yang Z, Qu X, Yang Z, Batinic-Haberle I, Spasojevic I, et al. Intracarotid Infusion of Redox-Active Manganese Porphyrin, MnTnBuOE-2-PyP⁵⁺, following Reperfusion Improves Long-Term, 28-Day Post-Stroke Outcomes in Rats. Antioxidants. 2023; 12(10):1861. https://doi.org/10.3390/antiox12101861

Li, Xuan, Weina Duan, Li Du, Dongmei Chu, Peng Wang, Zhong Yang, Xingguang Qu, Zhenxing Yang, Ines Batinic-Haberle, Ivan Spasojevic, and et al. 2023. "Intracarotid Infusion of Redox-Active Manganese Porphyrin, MnTnBuOE-2-PyP⁵⁺, following Reperfusion Improves Long-Term, 28-Day Post-Stroke Outcomes in Rats" Antioxidants 12, no. 10: 1861. https://doi.org/10.3390/antiox12101861

Li, X., Duan, W., Du, L., Chu, D., Wang, P., Yang, Z., Qu, X., Yang, Z., Batinic-Haberle, I., Spasojevic, I., Warner, D. S., Crapo, J. D., Treggiari, M. M., & Sheng, H. (2023). Intracarotid Infusion of Redox-Active Manganese Porphyrin, MnTnBuOE-2-PyP⁵⁺, following Reperfusion Improves Long-Term, 28-Day Post-Stroke Outcomes in Rats. Antioxidants, 12(10), 1861. https://doi.org/10.3390/antiox12101861